Pfizer investigational gene therapy for DMD fails in Phase 3 study
The overall safety profile of fordadistrogene movaparvovec in the CIFFREO trial was manageable, with mostly mild to moderate…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.